Publications

Clinical trials of tuberculosis vaccines in the era of increased access to preventive antibiotic treatment.

Rangaka, MX; Frick, M; Churchyard, G; García-Basteiro, AL; Hatherill, M; Hanekom, W; Hill, PC; Hamada, Y; Quaife, M; Vekemans, J; WHITE, RG; Cobelens, F;

2023

The Lancet. Respiratory medicine, (2023).11 4 10.1016/s2213-2600(23)00084-x.

Contribution of remote M.tuberculosis infection to tuberculosis disease: A 30-year population study.

GLYNN, JR; KHAN, P; Mzembe, T; Sichali, L; FINE, PE M; CRAMPIN, AC; HOUBEN, RM G J;

2023

PloS one, (2023).18 1 10.1371/journal.pone.0278136.

Demonstrating multi-country calibration of a tuberculosis model using new history matching and emulation package - hmer.

SCARPONI, D; Iskauskas, A; CLARK, RA; Vernon, I; McKinley, TJ; Goldstein, M; Mukandavire, C; Deol, A; Weerasuriya, C; Bakker, R; WHITE, RG; MCCREESH, N;

2023

Epidemics, (2023).43, 10.1016/j.epidem.2023.100678.

New tuberculosis vaccines in India: Modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01 E and BCG-revaccination.

CLARK, RA; Weerasuriya, CK; Portnoy, A; Mukandavire, C; Quaife, M; Bakker, R; SCARPONI, D; Harris, RC; Rade, K; Mattoo, SK; Tumu, D; Menzies, NA; WHITE, RG;

2023

medRxiv (2023). 10.1101/2023.02.24.23286406.

Cost-effectiveness of tuberculosis infection prevention and control interventions in South African clinics: a model-based economic evaluation informed by complexity science methods.

BOZZANI, FM; MCCREESH, N; Diaconu, K; GOVENDER, I; WHITE, RG; Kielmann, K; GRANT, AD; VASSALL, A;

2023

BMJ Global Health, (2023).8 2 10.1136/bmjgh-2022-010306.

The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study.

Portnoy, A; CLARK, RA; Quaife, M; WEERASURIYA, CK; Mukandavire, C; Bakker, R; Deol, AK; Malhotra, S; Gebreselassie, N; Zignol, M; Sim, SY; Hutubessy, RC W; Baena, IG; Nishikiori, N; JIT, M; WHITE, RG; Menzies, NA;

2023

PLOS Medicine, (2023).20 1 10.1371/journal.pmed.1004155.

The global impact of household contact management for children on multidrug-resistant and rifampicin-resistant tuberculosis cases, deaths, and health-system costs in 2019: a modelling study.

Dodd, PJ; Mafirakureva, N; Seddon, JA; MCQUAID, CF;

2022

The Lancet. Global health, (2022).10 7 10.1016/S2214-109X(22)00113-9.

Barriers to tuberculosis case finding in primary and secondary health facilities in Ghana: perceptions, experiences and practices of healthcare workers.

Der, JB; GRANT, AD; GRINT, D; Narh, CT; Bonsu, F; BOND, V;

2022

BMC health services research, (2022).22 1 10.1186/s12913-022-07711-1.

The potential impact of novel tuberculosis vaccines on health equity and financial protection in low- and middle-income countries.

Portnoy, A; CLARK, R; WEERASURIYA, C; Mukandavire, C; Quaife, M; Bakker, R; Garcia Baena, I; Gebreselassie, N; Zignol, M; JIT, M; WHITE, R; Menzies, N;

2022

medRxiv (2022). 10.1101/2022.10.29.22281678.

Updating age-specific contact structures to match evolving demography in a dynamic mathematical model of tuberculosis vaccination.

WEERASURIYA, CK; Harris, RC; MCQUAID, CF; Gomez, GB; WHITE, RG;

2022

PLoS Computational Biology, (2022).18 4 10.1371/journal.pcbi.1010002.